胃蛋白酶口服液联合肥儿疳积颗粒治疗小儿腹胀伴便秘的疗效观察

Effect Observation on Pepsin Oral Liquid Combined with Feier Ganji Granules in the Treatment of Infantile Burbulence Associated with Constipation

为观察胃蛋白酶口服液联合肥儿疳积颗粒治疗小儿腹胀伴便秘的疗效,将腹胀伴有便秘的80例患儿随机分为观察组和对照组,每组40例。对照组患儿给予常规治疗,观察组患儿在对照组治疗的基础上给予胃蛋白酶口服液联合肥儿疳积颗粒治疗,观察2组患儿的疗效,腹胀消失时间、食欲改善时间、每周排便次数、便秘改善情况以及并发症发生情况。结果显示,观察组患儿治疗总有效率高于对照组(P<0.05);观察组患儿腹胀消失时间、食欲改善时间短于对照组(P<0.05),每周排便次数多于对照组(P<0.05);观察组患儿每日排便1次占87.50%(35/40),对照组为60.00%(24/40),且观察组患儿大便转润占97.50%(39/40),对照组为75.00%(30/40),2组比较差异均有统计学意义(P<0.05);观察组患儿并发症发生率明显低于对照组(P<0.05)。结果表明,胃蛋白酶口服液联合肥儿疳积颗粒用于腹胀伴便秘患儿的临床效果更好,患儿经治疗后其症状均明显改善,且未出现其他并发症,对患儿的预后有着积极影响,值得临床推广应用。

This study was to observe the effect of pepsin oral liquid(Liquid)plus feier ganji granules(Granules)in the treatment of infantile burbulence associated with constipation,80pediatric patients with above conditions were randomly divided into control group(40cases,routine treatment)and observation group(40cases,Liquid plus Granules based on routine treatment);then,observed both groups'effect,the time for burbulence disappeared and for appetite improved,the status on constipation improved,the timenumbers of defecation per week,as well as complication incidence.As results,in total effective rate;in the time for burbulence disappeared,and for appetite improved;in defecation frequency per week,in the ratio of stool turned to wettings,and in complication incidence observation group was respectively higher,shorter,more,larger(39/40,97.5%vs 30/40,75%),and lower than control group(all,P<0.05);what's more,1 time/day for defecation in 87.5%(35/40)of pediatric patients of observation group,meanwhile,in 60.00%(24/40)of pediatric patients of control group.Results show that Liquid plus Granules in the treatment of infantile burbulence associated with constipation has more better efficacy:symptoms improved significantly,also without other complication,with active role on pediatric patients'prognosis.